
Atrion Corporation ATRI
Quarterly report 2024-Q2
added 05-16-2026
Atrion Corporation DPO Ratio 2011-2026 | ATRI
Annual DPO Ratio Atrion Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.9 | 12.1 K | 26.3 K | 27.7 | 23.3 | 20.4 | 19.1 | 19.1 | 19.2 | 22.9 | 21.6 | 22.3 | 23 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.3 K | 19.1 | 2.98 K |
Quarterly DPO Ratio Atrion Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 0.32 | 6.18 | 6.23 | - | - | - | 11.7 | - | - | - | 13.3 | - | - | - | 11 | - | - | - | 10.1 | - | - | - | 8.77 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 | 0.32 | 8.44 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
72.6 | $ 66.5 | 7.22 % | $ 13.2 B | ||
|
Glaukos Corporation
GKOS
|
61.5 | $ 124.71 | 2.4 % | $ 7.13 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
23.9 | $ 425.61 | 1.62 % | $ 152 B | ||
|
Alcon
ALC
|
63.6 | $ 66.76 | 0.3 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
39.2 | $ 137.33 | 1.78 % | $ 3.38 B | ||
|
iRhythm Technologies
IRTC
|
7.87 | $ 108.22 | 0.81 % | $ 3.46 B | ||
|
LeMaitre Vascular
LMAT
|
13.9 | $ 94.55 | 1.05 % | $ 2.14 B | ||
|
Repro Med Systems
KRMD
|
46.1 | $ 4.0 | -3.5 % | $ 185 M | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Masimo Corporation
MASI
|
84.4 | $ 178.95 | 0.03 % | $ 9.54 B | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Microbot Medical
MBOT
|
34.9 | $ 1.87 | -4.41 % | $ 85.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
91.4 | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
66.3 | $ 0.41 | -5.71 % | $ 33.6 M | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
195 | $ 9.24 | -7.04 % | $ 78.4 K | ||
|
Envista Holdings Corporation
NVST
|
54.2 | $ 22.84 | -0.11 % | $ 3.84 B | ||
|
Haemonetics Corporation
HAE
|
39.4 | $ 71.1 | 1.83 % | $ 3.35 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
34.2 | $ 212.96 | 0.32 % | $ 20.9 B | ||
|
STAAR Surgical Company
STAA
|
37 | $ 30.32 | 1.54 % | $ 1.5 B | ||
|
InfuSystem Holdings
INFU
|
59.7 | $ 9.08 | -0.77 % | $ 188 M | ||
|
Teleflex Incorporated
TFX
|
47.7 | $ 132.48 | 0.31 % | $ 5.91 B | ||
|
Utah Medical Products
UTMD
|
17.8 | $ 67.6 | -0.57 % | $ 219 M | ||
|
Merit Medical Systems
MMSI
|
30.3 | $ 64.06 | 1.62 % | $ 3.79 B | ||
|
West Pharmaceutical Services
WST
|
45.7 | $ 318.09 | 0.26 % | $ 23 B | ||
|
DENTSPLY SIRONA
XRAY
|
53.7 | $ 9.86 | -0.2 % | $ 1.97 B | ||
|
Pulse Biosciences
PLSE
|
1.51 K | $ 25.96 | -3.64 % | $ 1.75 B | ||
|
Retractable Technologies
RVP
|
46 | $ 0.65 | -1.36 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 67.39 | 0.58 % | $ 222 M | ||
|
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
25.9 | $ 26.43 | -2.44 % | $ 1.26 B | ||
|
Stereotaxis
STXS
|
124 | $ 1.8 | -4.26 % | $ 164 M | ||
|
Baxter International
BAX
|
45.6 | $ 19.51 | 0.83 % | $ 10 B | ||
|
ResMed
RMD
|
34.9 | $ 197.56 | 1.68 % | $ 28.9 B | ||
|
AtriCure
ATRC
|
68.7 | $ 27.35 | 0.29 % | $ 1.31 B | ||
|
Harvard Bioscience
HBIO
|
42 | $ 6.16 | -4.94 % | $ 273 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
96.2 | $ 12.33 | 2.45 % | $ 504 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 152.36 | 1.93 % | $ 43.8 B | ||
|
Nephros
NEPH
|
39.8 | $ 3.58 | -0.28 % | $ 38 M | ||
|
OraSure Technologies
OSUR
|
40.1 | $ 4.04 | -3.24 % | $ 297 M | ||
|
Repligen Corporation
RGEN
|
32.2 | $ 122.69 | -3.05 % | $ 6.9 M |